Clinical trial
A 24-month Randomised Parallel Group Single-blinded Multi-centre Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
NCT03174886 is registered in ClinicalTrials.gov with Axon Neuroscience SE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 24-month Randomised Parallel Group Single-blinded Multi-centre Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
- Lead sponsor
- Axon Neuroscience SE
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- July 31, 2017
- Completion date
- November 30, 2020
- Enrollment
- 33 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.